I specialize in economic evaluation and priority setting research in health-related interventions. I am currently working on two projects. The first is an evaluation of the health, fiscal and macroeconomic impacts of different COVID-19 management strategies in low- and middle-income countries in order to inform in-country decision-makers. The second is the country translation phase of Disease Control Priorities 3 (DCP3), which involves adapting global evidence in order to design new health benefit packages in Pakistan and other settings in sub-Saharan Africa.  

My methodological focus is on cost-effectiveness analyses alongside randomized controlled trials in low- and middle-income countries and I have expertise in the areas of HIV and GBV. Recent trials I have worked on include: Cotrimoxazole Preventive Therapy discontinuation among HIV-positive adults in Uganda, GBV prevention strategies in Ghana and Rwanda, and enhanced demand creation to increase uptake of Voluntary Medical Male Circumcision in Tanzania.

I have experience in cost data collection and analysis, having worked in the areas syphilis testing (Tanzania, Zambia and Peru) and HIV point-of-care diagnostics (Tanzania and Zambia).

I have also conducted qualitative work in the areas of antiretroviral distribution (Botswana), antimalarial distribution (Madagascar), vaccine introductions (Rwanda, Ethiopia and Cameroon), substance abuse in high-risk populations (UK), and introduction of HIV diagnostic technologies (Tanzania and Zambia).